Helius Medical Technologies, Inc. (NASDAQ:HSDT) Sees Significant Increase in Short Interest

Helius Medical Technologies, Inc. (NASDAQ:HSDT) was the target of a large increase in short interest during the month of September. As of September 15th, there was short interest totalling 120,800 shares, an increase of 260.6% from the August 31st total of 33,500 shares. Based on an average daily volume of 232,500 shares, the days-to-cover ratio is presently 0.5 days.

Helius Medical Technologies Trading Down 0.9 %

NASDAQ HSDT traded down $0.01 on Friday, hitting $0.67. 98,823 shares of the company were exchanged, compared to its average volume of 335,335. The firm has a 50 day moving average of $0.77 and a two-hundred day moving average of $2.21. The company has a market cap of $2.41 million, a P/E ratio of -0.05 and a beta of 1.61. Helius Medical Technologies has a 1-year low of $0.65 and a 1-year high of $9.89.

Helius Medical Technologies (NASDAQ:HSDT) last released its earnings results on Monday, August 12th. The company reported ($0.64) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.50) by ($0.14). The business had revenue of $0.18 million for the quarter. Helius Medical Technologies had a negative net margin of 1,487.54% and a negative return on equity of 258.06%. During the same quarter in the previous year, the firm posted ($3.00) EPS.

Institutional Trading of Helius Medical Technologies

A hedge fund recently bought a new stake in Helius Medical Technologies stock. Armistice Capital LLC bought a new position in shares of Helius Medical Technologies, Inc. (NASDAQ:HSDT) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 130,000 shares of the company’s stock, valued at approximately $127,000. Armistice Capital LLC owned approximately 4.39% of Helius Medical Technologies as of its most recent filing with the Securities and Exchange Commission. 18.63% of the stock is currently owned by hedge funds and other institutional investors.

About Helius Medical Technologies

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.